(Q46419310)

22 December 2017

title

Infliximab therapy for 2 patients with Vogt-Koyanagi-Harada syndrome (English)

1 reference

22 December 2017

author name string

Yue Wang

series ordinal

1

1 reference

22 December 2017

Paul A Gaudio

series ordinal

2

1 reference

22 December 2017

publication date

1 July 2008

1 reference

22 December 2017

Ocular Immunology and Inflammation

published in

1 reference

22 December 2017

volume

16

1 reference

22 December 2017

issue

4

1 reference

22 December 2017

page(s)

167-171

1 reference

22 December 2017

Vogt-Koyanagi-Harada disease diagnostic criteria

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Vogt-Koyanagi-Harada Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

T-cell recognition and cytokine profile induced by melanocyte epitopes in patients with HLA-DRB1*0405-positive and -negative Vogt-Koyanagi-Harada uveitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Immunomodulatory therapy for Vogt-Koyanagi-Harada patients as first-line therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Biologic therapies for inflammatory eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Tumor necrosis factor blockade: mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Tumor necrosis factor antagonists: preliminary evidence for an emerging approach in the treatment of ocular inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

A prospective trial of infliximab therapy for refractory uveitis: preliminary safety and efficacy outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Evaluation of the effect on outcomes of the route of administration of corticosteroids in acute Vogt-Koyanagi-Harada disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Guidelines for the use of corticosteroids in the treatment of pulmonary sarcoidosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Safety of low dose glucocorticoid treatment in rheumatoid arthritis: published evidence and prospective trial data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Recurrent uveitis with bilateral exudative retinal detachment. 10-year-old boy with bilaterally impaired vision and eye pain. Vogt-Koyanagi-Harada syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Mycophenolate mofetil therapy for inflammatory eye disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Experience with cyclosporine in endogenous uveitis posterior

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Reactivation of latent tuberculosis by TNF blockade: the role of interferon gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Monoclonal antibody and intravenous immunoglobulin therapy for rheumatic diseases: rationale and mechanisms of action.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

Binding and Functional Comparisons of Two Types of Tumor Necrosis Factor Antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09273940802204527

10.1080/09273940802204527

21 January 2018

Identifiers

DOI

1 reference

22 December 2017

1 reference

22 December 2017